RHJA
Rice Hall James & Associates Portfolio holdings
AUM
$1.86B
This Quarter Return
-3.18%
1 Year Return
+33.9%
3 Year Return
+119.1%
5 Year Return
+206.57%
10 Year Return
+613.71%
AUM
$1.7B
AUM Growth
+$1.7B
(-6.5%)
Cap. Flow
-$9.57M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
26.27%
Holding
258
New
9
Increased
68
Reduced
165
Closed
10
Top Buys
| 1 |
LKQ Corp
LKQ
|
$11.1M |
| 2 |
Amdocs
DOX
|
$10.3M |
| 3 |
Shift4
FOUR
|
$9.21M |
| 4 |
Chart Industries
GTLS
|
$6.64M |
| 5 |
Amicus Therapeutics
FOLD
|
$5.21M |
Top Sells
| 1 |
Stride
LRN
|
$25.9M |
| 2 |
TKO Group
TKO
|
$9.39M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$8.36M |
| 4 |
Harmonic Inc
HLIT
|
$3.61M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$3.04M |
Sector Composition
| 1 | Healthcare | 32.28% |
| 2 | Technology | 27.73% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Communication Services | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ituran Location and Control
ITRN
$653M
| $17.7M | 1.04% |
489,917
-17,635
| -3% | -$638K |
|
27
LeMaitre Vascular
LMAT
$2.14B
| $17.7M | 1.04% |
210,622
-24,454
| -10% | -$2.05M |
|
28
ReposiTrak
TRAK
$297M
| $17.3M | 1.02% |
853,017
-74,295
| -8% | -$1.51M |
|
29
Supernus Pharmaceuticals
SUPN
$2.52B
| $16.9M | 0.99% |
515,889
-12,456
| -2% | -$408K |
|
|
30
Amicus Therapeutics
FOLD
$2.42B
| $16.4M | 0.96% |
2,010,104
+639,024
| +47% | +$5.21M |
|
31
RB Global
RBA
$21.3B
| $16.4M | 0.96% |
163,390
-2,262
| -1% | -$227K |
|
32
BioCryst Pharmaceuticals
BCRX
$1.74B
| $15.2M | 0.89% |
2,027,568
-53,748
| -3% | -$403K |
|
33
WIX.com
WIX
$8.05B
| $14.6M | 0.86% |
89,078
-700
| -0.8% | -$114K |
|
34
Franklin Covey
FC
$239M
| $14.5M | 0.85% |
523,795
-10,129
| -2% | -$280K |
|
35
Ingevity
NGVT
$2.11B
| $14.4M | 0.85% |
364,216
+7,947
| +2% | +$315K |
|
36
CRA International
CRAI
$1.28B
| $14.1M | 0.83% |
81,491
-3,156
| -4% | -$547K |
|
37
Alkermes
ALKS
$4.95B
| $14.1M | 0.83% |
426,585
-3,342
| -0.8% | -$110K |
|
38
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $13.9M | 0.82% |
624,545
-18,207
| -3% | -$404K |
|
39
Maximus
MMS
$4.99B
| $12.7M | 0.74% |
185,780
+13,234
| +8% | +$902K |
|
40
Shutterstock
SSTK
$746M
| $12.4M | 0.73% |
666,348
+118,828
| +22% | +$2.21M |
|
41
Bank OZK
OZK
$5.93B
| $12.3M | 0.72% |
283,520
-3,496
| -1% | -$152K |
|
42
Neurocrine Biosciences
NBIX
$13.5B
| $12.1M | 0.71% |
109,673
-959
| -0.9% | -$106K |
|
43
Acadia Pharmaceuticals
ACAD
$4.34B
| $11.2M | 0.66% |
672,223
-9,314
| -1% | -$155K |
|
44
CEVA Inc
CEVA
$520M
| $11.2M | 0.66% |
435,478
-11,883
| -3% | -$304K |
|
45
Evolus
EOLS
$477M
| $11.1M | 0.65% |
921,394
-26,887
| -3% | -$323K |
|
46
Pool Corp
POOL
$11.4B
| $10.7M | 0.63% |
33,711
-256
| -0.8% | -$81.5K |
|
47
Mirum Pharmaceuticals
MIRM
$3.75B
| $10.6M | 0.62% |
234,696
-4,303
| -2% | -$194K |
|
48
Gentex
GNTX
$6.07B
| $10.5M | 0.62% |
451,010
-3,873
| -0.9% | -$90.2K |
|
49
Liquidity Services
LQDT
$824M
| $9.48M | 0.56% |
305,782
-28,473
| -9% | -$883K |
|
50
Vail Resorts
MTN
$5.91B
| $9.46M | 0.56% |
59,139
-76
| -0.1% | -$12.2K |
|